Literature DB >> 12799318

N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress.

C Andrew Haber1, Tony K T Lam, Zhiwen Yu, Neehar Gupta, Tracy Goh, Elena Bogdanovic, Adria Giacca, I George Fantus.   

Abstract

Exposure to high concentrations of glucose and insulin results in insulin resistance of metabolic target tissues, a characteristic feature of type 2 diabetes. High glucose has also been associated with oxidative stress, and increased levels of reactive oxygen species have been proposed to cause insulin resistance. To determine whether oxidative stress contributes to insulin resistance induced by hyperglycemia in vivo, nondiabetic rats were infused with glucose for 6 h to maintain a circulating glucose concentration of 15 mM with and without coinfusion of the antioxidant N-acetylcysteine (NAC), followed by a 2-h hyperinsulinemic-euglycemic clamp. High glucose (HG) induced a significant decrease in insulin-stimulated glucose uptake [tracer-determined disappearance rate (Rd), control 41.2 +/- 1.7 vs. HG 32.4 +/- 1.9 mg. kg-1. min-1, P < 0.05], which was prevented by NAC (HG + NAC 45.9 +/- 3.5 mg. kg-1. min-1). Similar results were obtained with the antioxidant taurine. Neither NAC nor taurine alone altered Rd. HG caused a significant (5-fold) increase in soleus muscle protein carbonyl content, a marker of oxidative stress that was blocked by NAC, as well as elevated levels of malondialdehyde and 4-hydroxynonenal, markers of lipid peroxidation, which were reduced by taurine. In contrast to findings after long-term hyperglycemia, there was no membrane translocation of novel isoforms of protein kinase C in skeletal muscle after 6 h. These data support the concept that oxidative stress contributes to the pathogenesis of hyperglycemia-induced insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799318     DOI: 10.1152/ajpendo.00355.2002

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  67 in total

1.  Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Angela M Nivala; Jon C Gonzales; Kyle T Pfaffenbach; Dong Wang; Yuren Wei; Hua Jiang; David J Orlicky; Dennis R Petersen; Michael J Pagliassotti; Kenneth N Maclean
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

Review 2.  Linking mitochondrial bioenergetics to insulin resistance via redox biology.

Authors:  Kelsey H Fisher-Wellman; P Darrell Neufer
Journal:  Trends Endocrinol Metab       Date:  2012-02-02       Impact factor: 12.015

3.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

Review 4.  N-acetylcysteine -- passe-partout or much ado about nothing?

Authors:  Mirja-Liisa Aitio
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

5.  Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes.

Authors:  Sukhdev Singh Kamboj; Kanwaljit Chopra; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2008-09-19       Impact factor: 3.584

6.  Hyperglycemia (high-glucose) decreases L-cysteine and glutathione levels in cultured monocytes and blood of Zucker diabetic rats.

Authors:  Preeti Kanikarla-Marie; David Micinski; Sushil K Jain
Journal:  Mol Cell Biochem       Date:  2019-06-06       Impact factor: 3.396

Review 7.  Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis.

Authors:  Hideaki Kaneto; Naoto Katakami; Munehide Matsuhisa; Taka-aki Matsuoka
Journal:  Mediators Inflamm       Date:  2010-02-16       Impact factor: 4.711

8.  A conceptual framework for predicting and addressing the consequences of disease-related microvascular dysfunction.

Authors:  Penn M McClatchey; Jefferson C Frisbee; Jane E B Reusch
Journal:  Microcirculation       Date:  2017-08       Impact factor: 2.628

9.  Metabolic signatures suggest o-phosphocholine to UDP-N-acetylglucosamine ratio as a potential biomarker for high-glucose and/or palmitate exposure in pancreatic β-cells.

Authors:  Saleem Yousf; Devika M Sardesai; Abraham B Mathew; Rashi Khandelwal; Jhankar D Acharya; Shilpy Sharma; Jeetender Chugh
Journal:  Metabolomics       Date:  2019-03-29       Impact factor: 4.290

10.  Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-alpha and adiponectin expression in rat adipocytes.

Authors:  L Xi; Z Qian; G Xu; C Zhou; S Sun
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.